HOME >> BIOLOGY >> NEWS
A test case for DNA barcodes to identify species

Faced with what Ed Wilson calls the "worst wave of extinction since the dinosaurs died," the need for a fast and easy way to identify species has never been greater. With too few specialists to do the job, biologists are looking for high-throughput tools that can rapidly and accurately identify individuals from known species and from an entirely new species. In the open access journal, PLoS Biology, Paul Hebert and colleagues demonstrate the utility of their controversial "DNA barcoding" concept, which uses genes to identify species much like supermarket barcodes identify products. Using a region of one specific gene, they correctly identify 260 North American bird species.

The idea is that a short stretch of genetic code from a reference gene is sufficiently characteristic of one species to distinguish it from every other species, and that comparisons of sequence variations in that gene can also reveal evolutionary relationships among species. Hebert and colleagues tested the effectiveness of their genetic barcode in an extensive study of North American birds by comparing the 'species' identified from the barcode against those already established by taxonomic methods. They found that all 260 bird species had unique genetic barcodes. In the 130 species represented by two or more individuals, gene sequences were either identical or closest to other sequences within that species. The authors report that the genetic barcodes therefore "separate individuals into the categories that taxonomists call species."

As their technology matures, it could radically advance biologists' attempts to achieve the long-standing goal of cataloging life on earth, but the approach is very controversial, with critics questioning both the method and its applications. As Craig Moritz and Carla Cicero from the University of California, Berkeley, also point out in the correspondence section of this issue, the Hebert et al. study is "not yet a definitive test of the utili
'"/>

Contact: Paul Ocampo
pocampo@plos.org
415-624-1224
Public Library of Science
27-Sep-2004


Page: 1 2

Related biology news :

1. Researchers identify protein promoting vascular tumor growth
2. Researchers identify distinctive signature for metastatic prostate cancer
3. Researchers identify the genomes controlling elements
4. Penn scientists identify novel pathway in aneurysms
5. Scientists identify compounds that mimic calorie restriction
6. Researchers identify gene for a primary form of sudden infant death sydrome (SIDS)
7. Scientists identify molecular link driving spread of skin cancer
8. Joslin researchers identify key molecule in Type 1 diabetes progression
9. Scientists identify cells that lead to retinoblastoma
10. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly
11. Researchers identify two potential protein targets for new drug therapies for pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: test case for DNA barcodes identify species

(Date:5/21/2013)... at Chicago College of Medicine will study gender differences in ... energy source -- and how changes in fat metabolism play ... 4-year grant from the National Heart, Lung and Blood Institute. ... for energy. These changes may play a major role in ... and women, says E. Douglas Lewandowski, director of the UIC ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
(Date:5/21/2013)... May 21, 2013 Alpha Source, ... , will be exhibiting for the 13th consecutive ... Medical Instrumentation (AAMI) 2013 Conference and Expo. The ... distribute, and manufacture healthcare technologies. This year’s event ... Beach, California. , The three-day event draws ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 As ... a strong push within the industry to deliver ... Manufacturing Organizations and pharma companies often means turning ... , Microtablets, developed in collaboration with Sensidose AB ... outsourcing can bring products to market sooner. The ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: